New England Biolabs

Breton Hornblower, Ph.D.

Portfolio Manager, Regulated Markets
New England Biolabs
  • Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs® (NEB®) is proud to be a world leader in the discovery and production of enzymes for molecular biology applications.
  • NEB researchers characterize and develop enzymes and workflows to further advance the analysis and characterization of mRNA to ensure product quality, efficacy and safety.
  • NEB’s portfolio of reagents enables bench-scale to commercial-scale mRNA manufacturing, enabling a seamless transition to large-scale therapeutic mRNA manufacturing.
  • During the COVID-19 pandemic, NEB applied the deep manufacturing and scientific expertise necessary to dramatically scale enzyme manufacturing at the unprecedented pace required to support vaccine manufacturing.

Dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines.